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Background: Hypoxic pulmonary artery hypertension (PAH) as a severe pulmonary disease is characterized by
changes of pulmonary vascular reconstruction. Mitochondrial ATP-sensitive potassium channel (mitoKATP) was
considered as one of factors responsible for the proliferation of hypoxic pulmonary arterial smooth muscle cells
(PASMCs), although the exact mechanisms remain unclear.
Methods: Pulmonary artery hypertension was induced in rats with or without 5-hydroxydecanoate (5-HD). The
mean pulmonary artery pressure, morphologic changes, mRNA and protein expressions of voltage-gated potassium
channels (Kv1.5 channel), were measured. The concentrations of monocyte chemo-attractant protein-1 (MCP-1) and
transforming growth factor-beta1 (TGF-β1) were detected. Furthermore, pulmonary arterial smooth muscle cells
(PASMCs) were isolated and cultured with or without hypoxia pretreated with or without 5-HD or/and Kv1.5 inhibitor
4-aminopyridine (4-AP). Mitochondrial membrane potential (Δψm) and the proliferation of PASMCs were detected.
Results: 5-HD significantly prevented the development of PAH by blocking the mitochondrial membrane
depolarization, increased the expression of voltage-gated potassium channels, and reduced pulmonary hypertension
mediated by TGF-β1 or MCP-1 signaling pathway.
Conclusion: The MitoKATP plays an important role in the development of PAH and may be therapeutic target for the
treatment of disease.
Keywords: 5-hydroxydecanoate, Mitochondrial ATP-sensitive potassium channel, Hypoxia, Kv1.5 channel, Pulmonary
artery hypertensionBackground
PAH is a severe form of lung disease, leading to right ven-
tricular failure or death. Hypoxic pulmonary vasoconstric-
tion is the very important physiological phenomenon
which optimizes ventilation–perfusion matching. How-
ever, sustained pulmonary vasoconstriction and pulmon-
ary artery remodeling could lead to PAH, as a complex
phenomenon involving multiplicity of interacting mecha-
nisms which has still not been elucidated. There is grow-
ing evidence that mitochondria as a key event is
responsible for initiation of PAH [1-4]. Mitochondrion as
the cell energy factory is sensitive to hypoxia and plays a
crucial role in hypoxia-mediated cell proliferation and* Correspondence: chenchengshui@126.com
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stated.apoptosis [5]. The Kv channel of PASMCs can directly
respond to the oxygen tension by controlling resting
membrane potential and regulating vasomotor. The
Kv1.5 was found as the primary oxygen-sensitive sub-
type [6], probably involved in hypoxic PAH. The ex-
pression of TGF-β1 in lung tissues regulated by
hypoxia could modulate PASMCs proliferation, which
is tissue-specific and modulated by the cellular micro-
environment [7]. Reactive oxygen species (ROS) could
be detected in both the mitochondrial matrix and cyto-
sol, which augment TGF-β-induced profibrotic gene ex-
pression [8]. MCP-1 is a potent chemo-attractant and
an activator for mononuclear cells. Mitochondrial un-
coupling under hypoxia-independent adipocytes can re-
duce MCP-1 release through induction of endogenous
ER stress and activation of AMP-activated potein kin-
ase [9]. TGF-β and MCP-1 were found to be closelytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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PAH [10].
The mitoKATP is a key factor in the control of mito-
chondrial membrane potential (Δψm), which is sensitive
to hypoxia. The previous study showed that hypoxia could
activate mitoKATP channels cause the depolarization of
Δψm and block the mitochondrial electron transport
chain, stimulate mitochondrial H2O2 overproduction, in-
crease cytochrome C accumulation, or increase the ex-
pression of HIF-1 α [11,12], resulting in an imbalance
between proliferation and apoptosis in hPASMCs. It has
been reported that opening or closure of mitoKATP may
be involved in the modulation of mitochondrial protein
complexes such as ROS-producing complex II and ANT-
regulated mitochondrial permeability transition pore [13].
Administration of 5-HD could inhibit mitoKATP and pre-
vent from hypoxia- and diazoxide-induced proliferation
through voltage-gated K + channel [14,15]. So far, there
has not been any reports as to whether mitoKATP plays
any important role in vivo, and the studies about the
modulation mechanism of mitoKATP on TGF-β and
MCP-1 are rarely documented. The mechanism by which
TGF-β1 and MCP-1 increases during hypoxia is unclear.
The present study aims at investigating the important role
of mitoKATP in hypoxic-induced PAH in vivo, to measure
alterations of Kv1.5 expression, TGF-β1 and MCP-1.
Methods
Reagents
5-HD with the purity of 99%, 4-aminopyridine (4-AP),
and rhodamine-123 (R-123) were purchased from
Sigma (USA). Polyclonal mouse anti-rat α-actin anti-
body (α-SM actin), polyclonal goat anti-rat Kv1.5 anti-
body, goat anti-rat MCP-1 antibody, and rabbit anti-rat
TGF-β1 antibody were purchased from Santa Cruz
(USA). Cell counting kit-8 (CCK) was purchased from
Tongue Chemical Institutes (Japan).
Animal model
Thirty adult male Sprague–Dawley rats, weighing 250–
300 grams, were obtained from Hays Lake Animal Co.
Ltd (Shanghai, China). Rats in the present study were
handled in accordance with the guidelines of Wenzhou
Medical College and National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
The study was approved by the Animal Ethics Commit-
tee of Wenzhou Medical College including permit
number SCXK (Zhejiang 2005–0019 150). Twenty four
rats were randomly divided into three groups (n = 8 per
group): 1) animals with manipulations with normoxia
(Controls); 2) animals with hypoxia and pretreated with
vehicle (Hypoxia + V); or 3) animals with hypoxia and
pretreated with 5-HD (Hypoxia +5-HD). Animals were
exposed to normoxia or hypoxia for one week and thenintraperitoneally injected (i.p.) with vehicle (0.9% saline)
or 5-HD (5 mg/kg/day) with a continuous hypoxic ex-
posure for 3 weeks. Hypoxia was achieved by placing
animals in a hypoxic chamber with the oxygen level at
10 ± 0.5%. PASMCs were isolated and cultured from six
rats randomly with normoxia, hypoxia pretreated with ve-
hicle, or hypoxia pretreated with 5-HD at 500 mmol/L,
or hypoxia with 5-HD and 4-AP (Kv1.5 inhibitor) at
10 mmol/L for 24 hours.
Measurements of pulmonary hypertension
The animals were weighed and intra-peritoneally anes-
thetized with chloral hydrate at the dose of 1 g/kg. The
right jugular vein was dissected and cannulated with
the heparinized polyethylene catheter-1106 which was
connecting with YL-4-type pressure transducer linked
to the Power lab data acquisition unit (AD Instruments,
Australia). The waveforms of the pulmonary arterial
pressure were recorded to calculate the mean pulmon-
ary artery pressure (mPAP), after the waveform was
stable [16]. Levels of mPAP were measured and the left
lung tissue was then harvested and fixed in 4% parafor-
maldehyde, dehydrated, embedded in paraffin, sliced
and stained with anti-α-SM-actin monoclonal antibody
(Santa Cruz, USA, 1:150) to detect the cytoskeleton
protein α-actin expression of PASMCs. The secondary
antibody in the absence of the primary antibody was
used as a negative control. Ten alveolar ducts (ADs)
with a diameter of 20- 150 μm and positive expression
of brown cytoplasm were randomly selected to deter-
mine the average optical density (A) of the α-SM-actin
protein expression using Image-ProPlus 6.0 software. A
hilar-level cross-section of the lung tissue was cut into
a size of 1 × 1 × 2 mm, which was immobilized with
2.5% glutaraldehyde and postfixed with 1% osmium tet-
roxide, and then embedded with Epon812. Sliced tis-
sues were processed with LKV-V-type ultra-thin slicing
machine, sliced and dyed. The ultra-structure of pul-
monary arterioles was examined with H-600 transmis-
sion electron microscope.
Measurement of MCP-1
The serum levels of MCP-1 were measured by enzyme
linked immunosorbent assay (ELISA) at the optical
density (absorbance, A) of 450 nm wavelength readout,
and expressed by pg/ml, according to the instructions of
ELISA.
Measurement of TGF-β1
Immuno-histochemisty was performed according to the
manufacturers recommendations (Santa Cruz Biotech-
nology, USA) to detect the expression of TGF-β1 in pul-
monary artery. The diluted concentration of antibody
TGF-β1 was 1:100, and the secondary antibody in the
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tive control. Small pulmonary arteries with diameters of
20 -150 μm were analyzed with Image-Pro Plus 6.0 soft-
ware. 6–8 fields of vision were selected from each sec-
tion for quantitative analyses.
Reverse transcription-polymerase chain reaction
Total RNA was rapidly obtained from pulmonary arter-
ies using Trizol (Invitrogen Life Technologies, USA).
RNA concentration was quantified using absorbance at
260 nm and the ratio of the absorbance at 260 and
280 nm (A260/280) was used to assess the purity of
RNA. Reverse transcription was performed at 42°C for
1 h and then at 95°C for 5 min. The resulting cDNA was
subjected to PCR amplification with specific primers.
PCR was performed with the M7122 Real-Time PCR in-
strument (Promega Life Technology, USA). The primers
used for Kv1.5 were as follows: 5′-CCA GCG AGT CCT
CAT AAA CA-3′ for the forward primer, and 5′-CAC
TAT GGC GAT GGC TCTT-3′ for the reverse primer.
The predicted amplification product size of Kv1.5 was
409 bp, and the product size of β-actin was 457 bp. The
following cycle parameters were used: 5 min at 94°C,
followed by 40 cycles of 1 min at 94°C and 45 s at 54°C
and 72°C for 45 s. Amplified products were visualized by
1.5% agarosgel electrophoresis with ethidium bromide
staining. The intensity of PCR product bands was quan-
tified by scanning densitometry. The relative expression
level of Kv1.5 mRNA was normalized to that of β-actin.
The statistical analysis of the PCR result was analyzed
using the Gelpro32 Software.
Western blot
Pulmonary arteries were homogenized and then lysed
using a strong Radio Immunoprecipitation Assay lysis
buffer and Phenylmethanesulfonyl fluoride. After cen-
trifuged at 12,000 rpm for 20 min at 4°C, the super-
natant was discarded, protein were quantified by the
method of BCA protein assay kit (Biyuntian biotechnol-
ogy company, Jiangsu, China) according to the manu-
facturer’s instructions. An equal amount of proteins
(75 μg) were separated by 10% SDS–polyacrylamide
gel electrophoresis and transferred onto polyvinylidene
fluoride membrane (Millipore, MA), and blocked with
triethanolamine-buffered saline containing 5% fat-free
milk powder for 1 hour. The membrane was then incu-
bated with specific primary antibodies: goat anti-Kv1.5
polyclonal antibody at 1:200 overnight at 4°C, and then
the corresponding secondary antibody (HRP-conju-
gated rabbit anti-goat IgG 1:5000 (Beijing Zhongshan
Biotechnology Co., Beijing, China) was added and incu-
bated for 2 h, The membrane was washed with tris-
buffered saline tween buffer for 10 min three times.
The immuno-reactive band was detected with BeyoECLPlus reagents. Enhanced chemiluminescence films were
processed using Gelpro32 image analysis system.
Cultured cells
The animals were anesthetized with chloral hydrate. Pul-
monary arteries at diameters of 2–3 mm were isolated
from the surrounding parenchyma and smooth muscle
bundles were dissected from the artery. Cells were
digested with 0.2% collagenase and subcultured. The dis-
sociated cells were resuspended in DMEM containing
20% FBS on culture flasks and maintained at 37°C in 5%
CO2 and at 95% humidity. The culture medium was
changed every 2 to 3 days until smooth muscle cells
were confirmed using immuno-fluorescence staining
with mouse anti-a-actin polyclonal antibody. Cells were
exposed to normoxia, hypoxia, hypoxia in the presence
of 5-HD at 500 mmol/L, and hypoxia in the presence of
5-HD with 4-AP at 10 mmol/L for 24 hours. Normoxia
was achieved by using a gas mixture of 74% N2, 5%
CO2, and 21% O2, and hypoxia was obtained by using a
gas mixture of 93% N2, 5% CO2, and 2% O2.
Measurement of PASMC proliferation
Cell proliferation was measured by CCK-8 assay (Dojindo,
Japan)based on the colorimetric measurement of forma-
zan dye formed from WST-8. Cells were seeded into a
flat-bottomed 96-well plate at a density of approximately
1 × 106 cells per millilitre, and incubated for 24 h in
serum-free medium. Cells were exposed to normoxia or
hypoxia in the presence of 5-HD or/and 4-AP for 24 h.
Cells were incubated with CCK-8 cell counting kit for
90 min in the absence of light at the end of treatments.
The absorbance of the solubilized product at 450 nm was
measured using the ELISA reader (Bio-TEK, USA). All the
measurements were conducted at least three times.
Mitochondrial membrane potential
The potential of mitochondrial membrane (Δψm) was mea-
sured as described previously [17]. Cells were exposed to 5-
HD or 5-HD plus 4-AP under hypoxia for 24 hours and
then incubated with rhodamine123 at 10 mg/ml (R-123;
Sigma, USA) for 30 min at 37°C. R-123 fluorescence was
excited at 488 nm and measured at 530 nm with a confocal
microscope (Olympus, Japan). The intensity of R-123 fluor-
escence was taken as an indicator of inner Δψm. The in-
crease in R-123 fluorescence represents the depolarization
of Δψm.
Data analysis
Statistical analyses were performed by SPSS software. All
data are expressed as mean ± SD. P values less than 0.05
was considered as statistically significant. One-way ana-
lysis of variance (ANOVA) was used for the comparisons
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used for multiple comparisons.
Results
Levels of mPAP in Hypoxia + V group significantly in-
creased as compared to Controls (p <0.05), Treatment of
the mitoKATP channel inhibitor 5-HD at 5 mg/kg/day for
3 weeks significantly prevented increased mPAP in hyp-
oxic rats (p <0.05; Figure 1A and B). Histo-pathological
examinations of lung tissues revealed that walls of distal
pulmonary arteries with positive expression of brown
cytoplasm became significantly thickened in Hypoxia + V
group, as compared with Controls, which was significantly
inhibited by the treatment with 5-HD. The expression of
smooth muscle-specific α-actin in pulmonary arterioles
significantly increased in Hypoxia + V group, but not in
group treated with 5-HD (p <0.05; Figure 1C and 1D). Flat
endothelial cells, regular intimal elastic lumina, small
PASMCs, and a few collagen fibers between PASMCs
were detected in lung tissues from Controls. Swollen
endothelial cells with a cubic shape, an amount of vacuoli-
zation along with the basal layer, or the crooked lumina
were observed in Hypoxia + V group. Hypoxia-induced
changes were significantly alleviated by treatment with 5-
HD (Figure 1E).
The expression of Kv1.5 mRNA in pulmonary arteries of
Hypoxia + V group significantly reduced as compared with
Controls (p < 0.05; Figure 2A), while not in group with 5-
HD. Expression of Kv1.5 protein significantly decreased in
Hypoxia + V group, while the treatment with 5-HD could
significantly inhibit hypoxia-induced low protein expres-
sion, as compared with Hypoxia + V (Figure 2B).
Positive expression of TGF-β1 was mainly detected in
pulmonary arteries and significantly increased in me-
dium and small pulmonary arteries in Hypoxia + V group
(p <0.05 vs controls; Figure 3A and B). Treatment with
5-HD could prevent from hypoxia-induced expression of
TGF-β1 in the pulmonary artery (p <0.05 vs Hypoxia + V).
Serum levels of MCP-1 in Hypoxia + V group significantly
increased vs Controls (p <0.05), while not in Hypoxia +
5-HD group, as show in Figure 3C.
Cultured PASMCs showed spindle-shaped features, as
well as the characteristic “hill and valley” appearance with
a prominent central oval nucleus under inverted phase
contrast microscope and positive staining of smooth
muscle-specific α-actin in Figure 4A. R-123 fluorescence
intensity increased in PASMCs 24 hours after hypoxia, as
an indication of depolarization of Δψm, which was signifi-
cantly inhibited by 5-HD treatment. The R-123 fluores-
cence intensity increased in the concomitant stimulation
of 4-AP and 5-HD, as compared with Controls or 5-HD
alone (Figure 4B). 5-HD attenuated hypoxia-induced
increase in R-123 fluorescence intensity. These results in-
dicated that hypoxia opens mitoKATP and induces anincrease in Δψm in PASMC, while 5-HD reverses the
depolarization of Δψm by voltage-gated potassium
channels (Kv1.5 channel). PASMC proliferation mea-
sured by CCK-8 colorimetric assay significantly in-
creased in Hypoxia + V and Hypoxia + 5-HD + 4-AP
groups, but not in Hypoxia + 5-HD alone, as compared
with Controls (p <0.05, Figure 4C).
Discussion
MitoKATP channels play an important role in the control
of membrane potential, energy production, homeostasis
and ROS generation [18]. It has been suggested that the
activation of the mitoKATP channel is regulated with the
decline of intracellular ATP levels and increase of intracel-
lular levels of nucleoside diphosphates in cardio-myocytes
[19]. The opening of mitoKATP could protect different cell
types against apoptosis, including cardiac myocytes, renal
epithelial cells, cere-bellar granule neurons, or skin cells
[20-23]. Hypoxia might provoke proliferation and lessen
apoptosis through mitochondrial apoptotic or proliferative
signaling pathway in hPASMCs [24]. 5-HD as a specific
mitoKATP inhibitor could inhibit PASMC mitochondrial
ATP sensitive potassium channel and the depolarization
induced by hypoxia [14]. PAH is a severe disease and ac-
counts for most deaths of chronic obstructive pulmonary
diseases, and remodeling of the pulmonary vessel wall
contribute to the increased pulmonary vascular resistance.
In the present study, we successfully established rat model
of PAH. Values of mPAP significantly increased compared
with controls. Results showed that pretreatment of rats
with 5-HD could block hypoxia-induced increase of
mPAP, the expression of smooth muscle-specific a-actin in
pulmonary arteries, and alterations of PASMC ultrastruc-
ture. The present study in vitro showed that hypoxia in-
duced depolarization of Δψm and promote PASMCs
proliferation, which was significantly inhibited by 5-HD
treatment. In the current study, Changes in Δψm, as indi-
cated by the intensity of R-123 fluorescence. It indicated
that mitoKATP channels was involved in and/or respon-
sible for hypoxia-induced pulmonary vascular remodel-
ing and the development of PAH. The inhibition of
mitoKATP channel with 5-HD could block hypoxic-
cellular responses in PASMCs and prevent the develop-
ment of PAH.
MitoKATP channels through ROS indirectly inhibit the
Kv1.5, open the voltage-gated calcium channels and in-
crease intracellular calcium influx, and caused PASMC
contraction and proliferation [25]. Down-regulation of
Kv1.5 channels was noticed to contribute to the develop-
ment PAH by promoting PA vasoconstriction and re-
modeling [26], and 5-HD could increase the expression
of Kv1.5 channel in hPASMCs [15]. The present study
in vivo demonstrated that the mitoKATP channel inhibi-
tor 5-HD could prevent the development of hypoxia-
Figure 1 Effects of mitochondrial ATP-sensitive potassium channel inhibitor (5-HD) on the development of pulmonary hypertension.
(A) Pulmonary arterial pressure (PAP) according to a right cardiac catheterization procedure; (B) The mean values of PAP (mPAP); (C) The Optimal
density (OD) of a-actin; (D) Immuno-histochemical staining of smooth muscle a-actin expression (×200); (E) Ultrastructural morphology in rat lung
tissues (×6000). Rats were treated with vehicle and normoxia as Controls, with vehicle and hypoxia (Hypoxia + V), or with 5-HD and hypoxia
(Hypoxia + 5-HD). Each group includes 8 animals and values were expressed as mean ± SD. *and + stand for p values less than 0.05, as compared
with Controls and Hypoxia + V group, respectively.
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tein expression of Kv1.5 in animals with hypoxia-induced.
To further study the mechanism of 5-HD, we investi-
gated Kv1.5 channel expression induced by hypoxiaand effects of 4-AP(Kv1.5 inhibitor)in cultured PASMCs.
The results further more evidenced that the combination
of 4-AP and 5-HD increased depolarization of Δψm
and increased proliferation, which mean that 5-HD
Figure 3 Effect of 5-HD on the localization of TGF-β1 and MCP-1 protein expression. (A) Positive expression of TGF-β1 was mainly detected
in pulmonary arteries and significantly increased in medium and small pulmonary arteries in Hypoxia + V group. (B) Treatment with 5-HD could
prevent from hypoxia-induced expression of TGF-β1 in the pulmonary artery. (C) Serum levels of MCP-1 in Hypoxia + V group significantly
increased vs Controls, while not in Hypoxia + 5-HD group. Each group includes 8 animals and values were expressed as mean ± SD. *and + stand
for p values less than 0.05, as compared with Controls and Hypoxia + V group, respectively.
Figure 2 Effect of 5-HD on mRNA (A) and protein expression (B) of Kv1.5 in pulmonary arteries. Rats were treated with vehicle and
normoxia as Controls, with vehicle and hypoxia (Hypoxia + V), or with 5-HD and hypoxia (Hypoxia + 5-HD). Each group includes 8 animals and
values were expressed as mean ± SD. *and + stand for p values less than 0.05, as compared with Controls and Hypoxia + V group, respectively.
Dong et al. Journal of Translational Medicine 2014, 12:39 Page 6 of 9
http://www.translational-medicine.com/content/12/1/39
Figure 4 Effect of 5-HD on Δ ψ m and proliferation in PASMCs. (A) Morphology of isolated PASMCs. (A1) PASMCs appeared spindle- shaped,
the typical “hill-and-valley” (phase contrast microscopy × 100); (A2) Positive expression of PASMCs α-actin appearance (Laser Confocal Micro-
scope × 400). (B) Effect of mitochondrial ATP-sensitive potassium channel inhibitor (5-HD) on hypoxic depolarization of mitochondrial membrane
potential in PASMCs treated with vehicle and normoxia as Controls, with vehicle and hypoxia (Hypoxia + V), with 5-HD and hypoxia (Hypoxia + 5-HD),
or with the combination of 5-HD and Kv1.5 inhibitor (4-AP) and hypoxia (Hypoxia + 5-HD + 4-AP), measured by the intensity of R-123 fluorescence
using a laser-scanning confocal microscope (B; ×200). (C) The proliferation of PASMC was measured by CCK-8 colorimetric assay. *and **stand for
p values less than 0.05 and 0.01, as compared with Controls, respectively, and + stands for p values less than Hypoxia + V group.
Dong et al. Journal of Translational Medicine 2014, 12:39 Page 7 of 9
http://www.translational-medicine.com/content/12/1/39could reverse the depolarization of Δψm by Kv1.5
channel.
Excessive TGF-beta signaling can initiates profibrotic
gene expression. The hypoxia-induced over-expression
of TGF-β1 was proposed to increase the expression of
NOx4 and oxygen free radicals through Smad2/3 signal
pathways and regulate the proliferation of PASMCs, re-
sponsible for pulmonary artery reconstruction [27,28].
The results of the current study showed that the produc-
tion of TGF-β1 from pulmonary arteries increased in
hypoxia, which can be prevented by 5-HD. It seems 5-
HD could influence TGF-β1-associated signal pathway
in pulmonary arteries.
MCP-1 may play a role in the initiation and/or pro-
gression of PAH. We found that hypoxia could increase
serum levels of MCP-1, which may be involved in the
interaction between leukocytes and pulmonary endothe-
lia to changes of pulmonary vascular smooth muscle
cells, e.g. increased vascular wall thickness, distal non-muscular artery to muscularization, or pulmonary vascular
to stenosis, especially for the small pulmonary arteries
[29,30]. Induction of mitochondrial reduces MCP-1 release
in mature 3 T3-L1 adipocytes maybe through AMPK-
related pathways [9]. The results of the present study con-
firmed that 5-HD could prevent hypoxia-induced elevated
serum levels of MCP-1, accompanied by reduction of pul-
monary vascular remodeling. It has been proposed that the
circulating levels of MCP-1 was regulated by MitoKATP,
although the exact mechanism which 5-HD altered sys-
temic levels of those cytokines induced by hypoxia remains
unclear.
Conclusion
In conclusions, we provided an in vivo evidence that the
inhibition of the mitoKATP channel could prevent
hypoxia-induced depolarization of mitochondrial mem-
brane potential via Kv1.5 channels, circulating of MCP-
1, and regulation of TGF-β1 signaling way. Other factors
Figure 5 5-HD down-regulates hypoxic-induced pulmonary artery hypertension. 5-HD could inhibit mitoKATP channels and block the
hypoxic depolarization of mitochondrial membrane potential of PASMCs via Kv1.5 channels, inhibiting the circulating inflammatory cytokines
MCP-1 and down-regulating TGF-β1 signaling way, or inhibiting PAH by oxygen free radicals (ROS)-related signal pathways.
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might be also involved in the mechanism of hypoxic
pulmonary vascular remodeling. The treatment of the
mitoKATP channel inhibitor could also alter the hypoxia-
induced PASMC proliferation, pulmonary vascular re-
modeling, and the development of PAH, as explained in
Figure 5. Thus, mitoKATP channels may play an import-
ant role in the formation of hypertension and should be
considered as one of therapeutic targets for PAH.
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